Annals ofOncology

Volume: 4 - Number: 27 - April 15, 2004

Outstanding

Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention

Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas

New HER2-directed Therapies for Breast Cancer.: Commentary re: C. I. Spiridon et al., Targeting Multiple Her-2 Epitopes with Monoclonal Antibodies Results in Improved Antigrowth Activity. Clin. Cancer Res., 8: 1720–1730, 2002.

Palpable Breast Cancers Are Inherently Different From Nonpalpable Breast Cancers

Advances

Patient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention

Editorial

Mitochondrial C-tract Alteration in Premalignant Lesions of the Head and Neck: A Marker for Progression and Clonal Proliferation

Molecular Effects of the Herbal Compound PC-SPES: Identification of Activity Pathways in Prostate Carcinoma

More is Less: Systemic Treatment for Local Control in Soft Tissue Sarcoma

MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer

Experimental Therapeutics

Pharmacokinetics of Intrathecal Gemcitabine in Nonhuman Primates

Investigational Article

Perceived Barriers and Benefits to Colon Cancer Screening among African Americans in North Carolina: How Does Perception Relate to Screening Behavior?

Phase I and Pharmacokinetic Study of Once Daily Oral Administration of S-1 in Patients with Advanced Cancer

Molecular and Genetic Biology

Phase I Clinical and Pharmacokinetic Study of NSC 655649, a Rebeccamycin Analogue, Given in Both Single-Dose and Multiple-Dose Formats

Oncological Markers

Pattern of Lymph Node Micrometastasis and Prognosis of Patients with Colorectal Cancer

Original article

Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas

Neoglycans, Carbodiimide-modified Glycosaminoglycans: A New Class of Anticancer Agents That Inhibit Cancer Cell Proliferation and Induce Apoptosis

New HER2-directed Therapies for Breast Cancer.: Commentary re: C. I. Spiridon et al., Targeting Multiple Her-2 Epitopes with Monoclonal Antibodies Results in Improved Antigrowth Activity. Clin. Cancer Res., 8: 1720–1730, 2002.

Noscapine Alters Microtubule Dynamics in Living Cells and Inhibits the Progression of Melanoma

Novel Anti-CD30 Recombinant Immunotoxins Containing Disulfide-stabilized Fv Fragments

Novel Mutation of Topoisomerase I in Rendering Cells Resistant to Camptothecin

Novel Therapy for Liver Cancer: Direct Intraarterial Injection of a Potent Inhibitor of ATP Production

Observation of Molecular Changes of a Necrotic Tissue from a Murine Carcinoma by Fourier-Transform Infrared Microspectroscopy

Occult Metastases in Sentinel Nodes of 200 Patients With Operable Breast Cancer

Outcome of Palliative Operations for Malignant Bowel Obstruction in Patients With Peritoneal Carcinomatosis From Nongynecological Cancer

Overexpression of Epidermal Growth Factor and Hepatocyte Growth Factor Receptors in a Proportion of Gastrinomas Correlates with Aggressive Growth and Lower Curability

Overexpression of Epidermal Growth Factor Receptor in Urothelium Elicits Urothelial Hyperplasia and Promotes Bladder Tumor Growth

Overexpression of Hypoxia-inducible Factor 1 Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

p27kip1 Expression Is Associated With Tumor Response to Preoperative Chemoradiotherapy in Rectal Cancer

p53, BCL-2, and Ki-67 Expression According to Tumor Response After Concurrent Chemoradiotherapy for Advanced Rectal Cancer

Palpable Breast Cancers Are Inherently Different From Nonpalpable Breast Cancers

Pathways of Lymphatic Drainage From the Breast